Using of curcumin as anti cancer agent is restricted by its low solubility, therefore it has low bioavability. This obstacle can be solved by the development of curcumin nanoparticle. Nanoparticle technology has been started to be developed as an alternative solution to improve drug delivery pofile, especially for the less bio-available chemical. This study was aimed to develope nanocurcumin fo…
Recently numerous prototype DNA-based biopharmecuticals can be used to control disease progression by induction and inhibitin the overexpression of Genes. Since there are poor cellular uptake and rapid in vivo the overexpression of DNA-based therapeutics therefore the use of delivery systems to facilitate cellular internalization and preserve their activity is necessary. Cationic polymers dommo…